Abstract:
To observe the biologic characteristics of Gd-DTPA labeled with
99Tc
m , the labeled compounds were prepared by reducing
99Tc
m in the presence of Gd-DTPA with stannous chloride. The labeling efficiency was measured by TLC(>98%, and stable at room temperature within 6 h). The plasma protein binding rate measured by the trichloroacetic acid method is (3.80±0.25)%. The bio-distribution in mice was observed by the blood sampling and other major organs that were taken out from mice at 1, 5, 10, 15, 30, and 60 min after intravenous injection of labeled compounds. The percentage of the injected dose per gram of tissues(%ID/g) of the blood and kidney are the highest level at 1 min after injection of
99Tc
m-DTPA-Gd. They are (14.79±9.77)%ID/g and (26.02±8.50)%ID/g, respectively. Heart, liver, spleen and lung have a little distribution of radiopharmaceuticals, and brain has the lowest level uptake less than 1%. The deposition of
99Tc
m-DTPA-Gd in other major organs was less than 1% at 30-60min after injection. Renal dynamic scintigraphy in rabbits are administrated, and show that
99Tc
m-DTPA-Gd is quickly excreted by kidney, and the time to peak is about 5-10 min, the half time of clearance is about 10-20 min. The animal experiments
in vivo and
in vitro show that
99Tc
m-DTPA-Gd and
99Tc
m-DTPA have the qualitatively similar biodistribution and excretion.
99Tc
m labeled Gd-DTPA may be a significant way not only to study its bio-distribution but also to directly observe its distribution and excretion by renal dynamic scintigraphy.